Source: Eur Respir Rev 2010; 19: 46-54
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Oh C. K., Geba G. P., Molfino N.. Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 2010; 19: 46-54

Member's Comments

No comment yet.

Related content which might interest you: Low power laser (LBP) therapy downregulates the allergic lung inflammation in experimental asthma model: Effect driven to signal transducer and activator of transduction 6 (STAT-6) Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Novel, highly potent and selective JAK3 inhibitor disrupting IL-4/IL-13 signaling in asthma therapy Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Targeting the interleukin pathway in the treatment of asthma Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001 New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5 Source: Eur Respir J 2001; 17: 499-506 Year: 2001 Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Transcription factor activation and mitogenic synergism in airway smooth muscle cells Source: Eur Respir J 2003; 21: 759-769 Year: 2003 New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Tumour necrosis factor and signal transducer and activator of transcription 3 pathways; novel targets to treat severe influenza virus infection Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Interleukin-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction Source: Eur Respir J 2005; 26: Suppl. 49, 2s Year: 2005 Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8 Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Combined effect of anti-IgE (omalizumab) and specific immunotherapy (SIT) on in vitro release of leukotrienes (LT) and the cytokines IL-4 and interferon-gamma (IFN) Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002 Expression of interleukin-4 receptor in bronchial asthma patients treated with specific immunotherapy (SIT) Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002 Increased activation of TGF beta signal transduction via Smad2/3 in the airways of mice lacking T-bet Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 Intermittent hypoxia activates the Interleukin (IL)-1ß and nuclear factor (NF)?B signaling pathway in primary murine macrophages Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019